Research Topic · Peer-Reviewed

Anti Cancer Therapy

Anti-cancer therapy encompasses the full range of treatments designed to destroy malignant cells, halt their proliferation, or restrain the progression of cancer. Conventional modalities include surgery, radiotherapy, and cytotoxic chemotherapy, while modern approaches increasingly exploit the molecular and immunolo…

Curated from this journal's research 📚 7 peer-reviewed articles cited Cited 99× across the literature 🔖 ISSN 2572-3030 🗓 Reviewed June 2026

Overview

Anti-cancer therapy encompasses the full range of treatments designed to destroy malignant cells, halt their proliferation, or restrain the progression of cancer. Conventional modalities include surgery, radiotherapy, and cytotoxic chemotherapy, while modern approaches increasingly exploit the molecular and immunological characteristics of tumours. Immunotherapy harnesses the patient's own immune system to recognise and attack cancer, and research in this area addresses both its therapeutic promise and the means of monitoring response, including immunoassays and immunogenomic approaches for immunomonitoring in cancer and infectious disease, and the relevance of immune-checkpoint markers such as PD-L1. Biomarker-guided strategies link treatment to tumour biology, exemplified by the study of dynamic microRNA expression in the plasma of melanoma patients as it relates to progression and survival, and by the identification of somatic mutations in signalling molecules within specific tumours. Natural-product chemistry also contributes candidates, as in the investigation of the anticancer properties of oligomeric proanthocyanidins. Significance lies in the shift toward targeted and immune-based treatment that aims for greater efficacy and selectivity than non-specific cytotoxic agents. Principal sub-areas include cytotoxic chemotherapy, radiotherapy, targeted molecular therapy, cancer immunotherapy and checkpoint modulation, biomarker-driven treatment selection, and the monitoring of therapeutic response through molecular and immunological measures.

Research published in this journal

7 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 7 articles above have been cited 99 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Anti Cancer Therapy, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Cancer Genetics And Biomarkers (ISSN 2572-3030).

Journal editorial board
Dr. Charlie Gourley · United Kingdom Dr. Xinyu Chen · United States Dr. Guru Prasad Maiti · United States

This page summarises published research for orientation; it is not medical or professional advice.